-
EP2985289
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2985289
| EP2985289 - Depletion of mouse cells for generic isolation of human cells upon xenotransplantation [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 06.01.2017 Database last updated on 02.09.2024 | Most recent event Tooltip | 06.01.2017 | Application deemed to be withdrawn | published on 08.02.2017 [2017/06] | Applicant(s) | For all designated states Miltenyi Biotec GmbH Friedrich-Ebert-Strasse 68 51429 Bergisch Gladbach / DE | [2016/07] | Inventor(s) | 01 /
Hardt, Olaf Miltenyi Biotec GmbH Sonnenweg 8 51061 Köln / DE | 02 /
Bosio, Andreas Miltenyi Biotec GmbH Hanfweg 17 50939 Köln / DE | 03 /
Agorku, David Miltenyi Biotec GmbH Sieversstrasse 29 51103 Köln / DE | [2016/07] | Representative(s) | Kisters, Michael Marcus Miltenyi Biotec B.V. & Co. KG Friedrich-Ebert Strasse 68 51429 Bergisch Gladbach / DE | [N/P] |
| Former [2016/07] | Kisters, Michael Marcus Patentanwalt Miltenyi Biotec GmbH Corporate Legal Department Friedrich-Ebert Strasse 68 51429 Bergisch Gladbach / DE | Application number, filing date | 14180939.2 | 14.08.2014 | [2016/07] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2985289 | Date: | 17.02.2016 | Language: | EN | [2016/07] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 20.11.2014 | Classification | IPC: | C07K14/705, C12N5/00 | [2016/07] | CPC: |
C12N5/0081 (EP,US);
G01N33/56966 (US);
C07K14/705 (EP,US);
G01N2333/70596 (US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2016/07] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | Abreicherung von Mauszellen zur generischen Isolierung humaner Zellen nach einer Xenotransplantation | [2016/07] | English: | Depletion of mouse cells for generic isolation of human cells upon xenotransplantation | [2016/07] | French: | Déplétion des cellules de souris pour isolation générique de cellules humaines lors d'une xénotransplantation | [2016/07] | Examination procedure | 18.08.2016 | Application deemed to be withdrawn, date of legal effect [2017/06] | 26.09.2016 | Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time [2017/06] | Fees paid | Penalty fee | Additional fee for renewal fee | 31.08.2016 | 03 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]WO2008115601 (UNIV JOHNS HOPKINS [US], et al) [Y] 1-8 * paragraph [00433] *; | [Y]WO2009045201 (BIOGEN IDEC INC [US], et al) [Y] 1-8 * page 28, line 7 - line 10 *; | [A]WO2012010904 (PROCURE THERAPEUTICS LTD [GB], et al) [A] 1-8* page 10, line 10 - line 12 *; | [Y] - S. B. WILLINGHAM ET AL, "The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, (20120326), vol. 109, no. 17, doi:10.1073/pnas.1121623109, ISSN 0027-8424, pages 6662 - 6667, XP055029983 [Y] 1-8 * page 6662, column r, paragraph l * DOI: http://dx.doi.org/10.1073/pnas.1121623109 | by applicant | - RUBIO-VIQUEIRA B; HIDALGO, M., CLIN. PHARMACOL. THER., (2009), vol. 85, pages 217 - 221 | - WONG, S.Q. ET AL., SCI. REP., (2013), vol. 3, page 3494 | - C.C. ZHANG ET AL., STEM CELLS TRANSL. MED., (2013), vol. 2, pages 233 - 242 | - MARANGONI E ET AL., CLIN CANCER RES., (20070701), vol. 13, no. 13, pages 3989 - 98 |